Location

Phoenix, Arizona

Contact

Porter.Alyx@mayo.edu Clinical Profile

SUMMARY

The research interests of Alyx B. Porter, M.D., are focused on inclusive cancer care and improving the quality of life and treatment of patients with brain tumors. Specifically, she focuses on patients diagnosed with meningioma, brain metastases, and gliomas, such as glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma and low-grade glioma.

Her work in inclusive cancer care includes improving access to clinical trials, reducing disparities in clinical trial enrollment and promoting workforce diversity. The ideal is for workforce diversity to be reflective of the patient population.

Focus areas

  • Quality of life. Dr. Porter is the primary investigator for the largest clinical trial to date evaluating a psychostimulant to reduce fatigue in patients with high-grade glioma. She continues to dedicate effort toward improving symptoms that result from cancer treatment.
  • Inclusive cancer care. Dr. Porter is actively involved in incorporating social determinants of health in clinical trial design. She also pursues opportunities to reduce barriers to access to care and enrollment in clinical trials for patients with neuro-oncologic diseases and varied elements of diversity.
  • Reducing disparities in neuro-oncology. Diverse patients deserve to see themselves represented in the health care workforce they trust with their care. Dr. Porter seeks to recognize improvements in trust, adherence and outcomes when they occur.

Significance to patient care

Dr. Porter aims to improve the quality of life of patients with brain cancer by helping them:

  • Identify better treatment options.
  • Reduce fatigue.
  • Maintain independence and autonomy.
  • Access and use known resources more effectively.

Additionally, she seeks to identify and eliminate barriers that directly or indirectly impact care for patients from diverse backgrounds.

Professional highlights

  • Medical director, Office of Access Management, Mayo Clinic in Arizona, 2022-present.
  • Board member, American Brain Foundation, 2021-present.
  • Medical director, Outpatient Practice, Mayo Clinic in Arizona, 2021-present.
  • Founder and executive director, ElevateMeD, 2019-present.
  • Co-chair, Central Nervous System Disease Group, Mayo Clinic Comprehensive Cancer Center, 2018-present.
  • Women in Neuro-Oncology Mid-Career Exemplary Physician Award, Society for Neuro-Oncology, 2020.

PROFESSIONAL DETAILS

Primary Appointment

  1. Department of Neurology
  2. Department of Neurologic Surgery

Academic Rank

  1. Associate Professor of Neurology

EDUCATION

  1. Fellow - Neuro-Oncology Neurology, Programs in Rochester, Mayo School of Graduate Medical Education
  2. Resident Student Senate, Bemidji State University
  3. Residency - Neurology Neurology, Programs in Rochester, Mayo School of Graduate Medical Education
  4. Resident Neurology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  5. Internship - Internal Medicine Preliminary Internal Medicine, Programs in Rochester, Mayo School of Continuing Medical Education, Mayo Clinic College of Medicine
  6. Resident Preliminary Internal Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  7. MD Temple University School of Medicine
  8. BA - English, Minor in Biochemistry Spelman College
.
BIO-10030808

Mayo Clinic Footer